I analyze the effects of four types of medical innovation and cancer incidence on US cancer mortality rates during the … pre‐dated factors that drove both innovation and mortality and that there would have been parallel trends in mortality in … the absence of innovation, the estimates indicate that there were three major sources of the 13.8% decline of the age …

contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …

Assessing the benefits of medical innovation—its impact on health outcomes—is as important as assessing the costs … that investigates the benefits and costs of another broad category of medical innovation—inpatient therapeutic procedure … innovation—using data on over one million hospital discharges. …

We investigate the impact of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey …

Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … death) and medical expenditure in France during the period 2000–2009. The estimates imply that pharmaceutical innovation …

contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …